BELLEVUE, WA, March 7 /CNW/ - Oncothyreon Inc. (the "Company")
(Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the
development of innovative therapeutic products for the treatment of cancer,
today announced that it intends to release its fourth quarter and full year
2007 financial results on Monday, March 10, 2008 after the close of the U.S.
and Canadian markets. Following the release, Oncothyreon's management expects
to discuss these financial results and give a general business update in a
conference call at 4:30 p.m. EST.
The discussion is planned for a live webcast and can be accessed at
www.oncothyreon.com. It is expected that the archive of the webcast will be
available approximately one hour after completion of the discussion and will
be posted on the Oncothyreon website for 30 days.
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.
For further information:
For further information: Investor and Media Relations Contact: Julie
Rathbun, Rathbun Communications, (206) 769-9219, firstname.lastname@example.org